Mpox

Mpox is a rare viral infection, with a recent increase in cases throughout many parts of the world, including Canada. The virus spreads through close, physical contact, particularly through contact with an infected person 91ÖÆÆ¬³§ ’s rash or bodily fluids such as blood, saliva, and semen. The virus may also spread through respiratory particles (e.g. from talking, breathing, coughing, sneezing) during prolonged close contact.

Symptoms include:

  • Rash (sometimes painful) on mouth, genitals, face, arm and legs, and feet and hands
  • Fever
  • Chills
  • Swollen glands
  • Headache
  • Muscle and joint pain
  • Exhaustion

People usually develop symptoms 5 to 21 days after exposure are contagious from the onset of symptoms until skin has healed.

If students experience symptoms, they should stay away from others and contact a healthcare provider immediately for advice on testing and medical care. This viral infection typically goes away on its own within 2-4 weeks but, in some cases, it can be severe and potentially life-threatening.

Mpox Vaccine

People who are eligible can get a two-dose vaccine which can be used to protect against Mpox (i.e., (Pre-Exposure Prophylaxis – PrEP) or after exposure (i.e., Post-Exposure Prophylaxis – PEP).

For more information about Mpox including who is eligible for the vaccine, see the and/or the websites.